# Digitalis Investigation Group (DIG)

> **NCT00000476** · PHASE3 · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)**

## Conditions studied

- Arrhythmia
- Cardiovascular Diseases
- Heart Diseases
- Heart Failure, Congestive
- Sinus Arrhythmia
- Heart Failure

## Interventions

- **DRUG:** digitalis

## Key facts

- **NCT ID:** NCT00000476
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1990-06
- **Primary completion:** —
- **Final completion:** 1998-06
- **Target enrollment:** — (—)
- **Last updated:** 2016-07-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000476

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000476, "Digitalis Investigation Group (DIG)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00000476. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*